Veeva Systems adds top 20 biopharma client for Vault CRM

PLEASANTON, Calif. - Veeva Systems (NYSE:VEEV) announced today that another top 20 biopharma company has committed to its Vault CRM platform, bringing the total to 14 of the top 20 biopharma firms, according to a press release statement.

The company stated that Vault CRM now has more than 190 live customers. Recent commitments include Amgen, Biogen, Eli Lilly and Company, and Regeneron.

Vault CRM is designed to serve as a customer relationship management system for life sciences companies. The platform includes features such as the Agentic Call Report, which generates what the company calls Commercial Evidence for commercial teams.

"We’re excited to work with customers as Vault CRM drives the shift to agentic commercial," said Arno Sosna, president of CRM Suite at Veeva. "Together, we’re establishing a fundamentally new way of working that helps bring medicines to patients faster and more efficiently with the next generation of CRM."

Vault CRM is part of the Veeva Vault CRM Suite, which connects sales, marketing, and medical functions for pharmaceutical and biotech companies.

Veeva Systems provides cloud-based software for the life sciences industry and serves more than 1,500 customers. The company operates as a Public Benefit Corporation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Our Fair Value model runs 17 proven valuation methods on VEEV and returns one number: what the stock is worth today, and how far the current price sits from it.Same calculation on thousands of other stocks — so you can see instantly whether VEEV is the best value on the table, or whether something cheaper is hiding in plain sight.